Kalemkerian GP - Search Results

1

Phase II study of celecoxib and docetaxel in non-small cell lung cancer (NSCLC) patients with progression after platinum-based therapy.

Schneider BJ, Kalemkerian GP, Kraut MJ, Wozniak AJ, Worden FP, Smith DW, Chen W, Gadgeel SM. Schneider BJ, et al. Among authors: kalemkerian gp. J Thorac Oncol. 2008 Dec;3(12):1454-9. doi: 10.1097/JTO.0b013e31818de1d2. J Thorac Oncol. 2008. PMID: 19057272 Free PMC article. Clinical Trial.

2

Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.

Kalemkerian GP, Slusher R, Ramalingam S, Gadgeel S, Mabry M. Kalemkerian GP, et al. J Natl Cancer Inst. 1995 Nov 15;87(22):1674-80. doi: 10.1093/jnci/87.22.1674. J Natl Cancer Inst. 1995. PMID: 7473815

3

Lung cancer in young patients: analysis of a Surveillance, Epidemiology, and End Results database.

Ramalingam S, Pawlish K, Gadgeel S, Demers R, Kalemkerian GP. Ramalingam S, et al. Among authors: kalemkerian gp. J Clin Oncol. 1998 Feb;16(2):651-7. doi: 10.1200/JCO.1998.16.2.651. J Clin Oncol. 1998. PMID: 9469354

4

Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer.

Joshi US, Chen YQ, Kalemkerian GP, Adil MR, Kraut M, Sarkar FH. Joshi US, et al. Among authors: kalemkerian gp. Cancer Gene Ther. 1998 May-Jun;5(3):183-91. Cancer Gene Ther. 1998. PMID: 9622102

5

A phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma: an Eastern Cooperative Oncology Group Study.

Kalemkerian GP, Jiroutek M, Ettinger DS, Dorighi JA, Johnson DH, Mabry M. Kalemkerian GP, et al. Cancer. 1998 Sep 15;83(6):1102-8. doi: 10.1002/(sici)1097-0142(19980915)83:6<1102::aid-cncr8>3.0.co;2-9. Cancer. 1998. PMID: 9740074 Clinical Trial.

6

Phase II study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung cancer.

Ali MA, Kraut MJ, Valdivieso M, Herskovic AM, Du W, Kalemkerian GP. Ali MA, et al. Among authors: kalemkerian gp. Lung Cancer. 1998 Oct;22(1):39-44. doi: 10.1016/s0169-5002(98)00064-6. Lung Cancer. 1998. PMID: 9869106 Clinical Trial.

7

Lung cancer in patients < 50 years of age: the experience of an academic multidisciplinary program.

Gadgeel SM, Ramalingam S, Cummings G, Kraut MJ, Wozniak AJ, Gaspar LE, Kalemkerian GP. Gadgeel SM, et al. Among authors: kalemkerian gp. Chest. 1999 May;115(5):1232-6. doi: 10.1378/chest.115.5.1232. Chest. 1999. PMID: 10334132

8

Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer.

Kalemkerian GP, Belzer K, Wozniak AJ, Gaspar LE, Valdivieso M, Kraut MJ. Kalemkerian GP, et al. Lung Cancer. 1999 Sep;25(3):175-82. doi: 10.1016/s0169-5002(99)00060-4. Lung Cancer. 1999. PMID: 10512128 Clinical Trial.

9

A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer.

Ali MA, Kraut MJ, Valdivieso M, Wozniak AJ, Cummings G, Kalemkerian GP. Ali MA, et al. Among authors: kalemkerian gp. Cancer Invest. 2000;18(1):1-5. doi: 10.3109/07357900009023055. Cancer Invest. 2000. PMID: 10701360 Clinical Trial.

10

Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer.

Krug LM, Miller VA, Kalemkerian GP, Kraut MJ, Ng KK, Heelan RT, Pizzo BA, Perez W, McClean N, Kris MG. Krug LM, et al. Among authors: kalemkerian gp. Ann Oncol. 2000 Feb;11(2):227-8. doi: 10.1023/a:1008349209956. Ann Oncol. 2000. PMID: 10761761 Free article. Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters